Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stichting Wetenschap Intergeneeskunde & MDL is a clinical research foundation based at the Medisch Centrum Leeuwarden (MCL) in the Netherlands. The foundation serves as the primary entity for managing and conducting scientific research within the hospital's departments of Internal Medicine and Gastroenterology/Hepatology. It facilitates a wide range of clinical studies, including investigator-initiated research and international multicenter trials sponsored by the pharmaceutical industry. The organization is particularly active in the fields of inflammatory bowel disease (IBD), liver pathology, and metabolic health. By integrating clinical care with rigorous scientific inquiry, the foundation supports the development of new therapeutic strategies and the optimization of existing treatment protocols. It operates under the umbrella of the MCL Academy, ensuring high standards of Good Clinical Practice (GCP) and ethical compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stichting Wetenschap Intergeneeskunde & MDL, Medisch Centrum Leeuwarden.